1998
Founded
Company
Independent. Global. Focused on innovation.
About ABX-CRO
Our History
Global
5 continents
30+
Years of expertise
The name ABX is closely linked to the development of modern molecular imaging and radiotherapy. In 1996, ABX advanced biochemical compounds were first to provide quality precursor compounds to the molecular imaging community, enabling today's industrial PET radiopharmaceutical production.
In 1998, recognising an unmet need for dedicated radiopharmaceutical development expertise, ABX established its CRO division, spun out in 2002 as ABX-CRO advanced pharmaceutical services, the world's first full service CRO specialising in nuclear medicine.
We have been involved in many important radiopharmaceutical product developments since. Today, molecular radiotherapy is an independent pillar of oncology.
Scientific Depth
Our Expertise
Radiopharmaceutical development requires navigating a complex intersection of imaging physics, pharmacology, nuclear medicine, clinical research and regulatory processes. We have spent more than two decades building a team that covers all of them. Across more than 70 radiopharmaceutical trials from phase 0 to phase III, we design the protocol, manage the sites and analyse clinical and imaging data — work that we deliberately keep integrated, because separating it costs time.
Explore Areas of ExpertiseDriving Innovation
Scientific Contributions
Winner of the EANM Marie Curie Award for dosimetry excellence
Developed IDAC-alpha, a dosimetry tool for multi alpha decay nuclides (Ra-223, Ac-225, Th-227)
Introduced QDOSE, a CE certified clinical dosimetry software suite
First to adopt quantitative SPECT reconstruction ("QSPECT") from NCCCRI Osaka in Europe
Conceived and launched the EANM Initiative for Multicentre Nuclear Medicine
Global Reach, Local Insight
Global Presence
Based in Dresden, Germany, with offices in Australia, South America, India, South Africa and the US, supported by a network of cooperating local CROs for worldwide coverage.
Central project design, management and quality assurance ensure consistent GxP compliant data across all environments.
One Integrated Team
One CRO, Not Two
We left the classical separation between clinical CRO and imaging core lab behind. ABX-CRO provides integrated or modular services from a single team, reducing inefficiencies and keeping management burden to a minimum so your trial can proceed at speed.
"We know that every project is unique. Looking forward to discussing yours."
Dr. Andreas KlugeGeneral Manager and Founder
Meet our Experts
Leadership Team
Dr. Andreas Kluge
Founder & General Manager
Dresden, Germany
Andreas Fintelmann
Managing Director
Dresden, Germany
Felix Husmann
Managing Director
Dresden, Germany
Moritz Kallerhoff
CEO, US
Boston, USA
Taranjit Singh
General Manager, India
New Delhi, India
Dr. Sabine Friedrich
Global Head of Operations and Regulatory Affairs
Dresden, Germany
Dr. Ole Voges
Medical Director
Dresden, Germany
Karl Schmidt
Director Image Core Lab
Dresden, Germany
Laurie Ben-yair
Director Data Management
Cape Town, South Africa
Antje Rochel
Director Quality Assurance
Dresden, Germany
Dr. Ulrike Schorr-Neufing
Director Personnel and Qualification
Dresden, Germany
Juliet Johnston
Business Development
Dresden, Germany
Claudia Flemming
Business Development
Dresden, Germany
Dr. Volker Meyer
Director Clinical Operations
Dresden, Germany
Meena Dam
Chief Operating Officer, US
Philadelphia, USA
Careers
Grow with ABX-CRO
ABX-CRO is an officially recognized German vocational training company (IHK-certified). We welcome talent at every career stage—from apprentices to senior scientists.
View Careers